Skip to main content
Screener/Healthcare/Biotechnology

RLMD — Relmada Therapeutics, Inc.

NASDAQ
$3.92+0.15 (+4.11%)
Small CapPenny StockUnder $5Healthcare
$2.42
$8.00
$3.69
$3.97
EPS (TTM)$-1.11
P/E Ratio-8.61
Dividend Yield—
Market Cap$402.1M
Volume814K
Prev Close$3.77
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$19.1M$-0.22——
Q4 '25$0-$19.9M$-0.29——
Q3 '25$0-$10.1M$-0.30——
Q2 '25$0-$9.9M$-0.30——
Q1 '25$0-$17.6M$-0.58——
Q4 '24$0-$18.7M$-0.62——
Q3 '24$0-$21.7M$-0.72——
Q2 '24$0-$17.8M$-0.59——
Get Your Daily Market Recap